Loss of the Osteogenic Differentiation Potential during Senescence Is Limited to Bone Progenitor Cells and Is Dependent on p53

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Despars, Geneviève ^a,b   Carbonneau, Cynthia L ^a,b   Bardeau, Pascal ^a,b   Coutu, Daniel L ^c   Beauséjour, Christian M ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL LOSS; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DAMAGE; IONIZING RADIATION; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOBLAST; OSTEOBLAST LIKE STROMAL CELL; PHENOTYPE; PROADIPOCYTE; PROTEIN FUNCTION; RADIATION EXPOSURE; SENESCENCE; UPREGULATION;

ADIPOGENESIS; ANIMALS; CELL AGING; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; MESENCHYMAL STROMAL CELLS; MICE; OSTEOCYTES; OSTEOGENESIS; RADIATION, IONIZING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84883215038     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073206     Document Type: Article

References (38)

1. Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, et al. (2008) Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 100: 1368-1379. doi:10.1093/jnci/djn310. PubMed: 18812549.
2. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, et al. (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355: 1572-1582. doi:10.1056/NEJMsa060185. PubMed: 17035650.
3. Kondo H, Searby ND, Mojarrab R, Phillips J, Alwood J, et al. (2009) Total-body irradiation of postpubertal mice with (137)Cs acutely compromises the microarchitecture of cancellous bone and increases osteoclasts. Radiat Res 171: 283-289. doi:10.1667/RR1463.1. PubMed: 19267555.
4. Green DE, Adler BJ, Chan ME, Rubin CT, (2012) Devastation of adult stem cell pools by irradiation precedes collapse of trabecular bone quality and quantity. J Bone Miner Res Off J American Society For Bone Mineral Res 27: 749-759. doi:10.1002/jbmr.1505.
5. Mostoufi-Moab S, Ginsberg JP, Bunin N, Zemel B, Shults J, et al. (2012) Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation. J Bone Miner Res Off J American Society For Bone Mineral Res 27: 760-769. doi:10.1002/jbmr.1499. PubMed: 22189761.
6. Brockstedt H, Kassem M, Eriksen EF, Mosekilde L, Melsen F, (1993) Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone 14: 681-691. doi:10.1016/8756-3282(93)90092-O. PubMed: 8274313.
7. Campisi J, (1996) Replicative senescence: An old lives tale? Cell 84: 497-500. doi:10.1016/S0092-8674(00)81023-5. PubMed: 8598035.
8. Hayflick L, (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614-636. doi:10.1016/0014-4827(65)90211-9. PubMed: 14315085.
9. Campisi J, d'Adda di Fagagna F, (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740. doi:10.1038/nrg2208. PubMed: 17667954.
10. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724. doi:10.1038/nature03890. PubMed: 16079850.
11. Collado M, Serrano M, (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10: 51-57. doi:10.1038/nrc2772. PubMed: 20029423.
12. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, et al. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLOS Biol 6: 2853-2868. PubMed: 19053174.
13. Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL, (2013) Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123: 966-972. doi:10.1172/JCI64098. PubMed: 23454759.
14. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, et al. (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479: 232-236. doi:10.1038/nature10600. PubMed: 22048312.
15. Cao JJ, Kurimoto P, Boudignon B, Rosen C, Lima F, et al. (2007) Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I. J Bone Miner Res Off J American Society For Bone Mineral Res 22: 1271-1279. doi:10.1359/jbmr.070506. PubMed: 17488198.
16. Abdallah BM, Haack-Sørensen M, Fink T, Kassem M, (2006) Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39: 181-188. doi:10.1016/j.bone.2005.12.082. PubMed: 16530029.
17. Stolzing A, Scutt A, (2006) Age-related impairment of mesenchymal progenitor cell function. Aging Cell 5: 213-224. doi:10.1111/j.1474-9726.2006.00213.x. PubMed: 16842494.
18. Stenderup K, Justesen J, Clausen C, Kassem M, (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926. doi:10.1016/j.bone.2003.07.005. PubMed: 14678851.
19. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. doi:10.1126/science.284.5411.143. PubMed: 10102814.
20. Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, et al. (2003) Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 22: 4212-4222. doi:10.1093/emboj/cdg417. PubMed: 12912919.
21. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, et al. (2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114: 1299-1307. doi:10.1172/JCI200422475. PubMed: 15520862.
22. Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, et al. (2004) Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 6: 168-170. doi:10.1038/ncb1095. PubMed: 14755273.
23. Zindy F, Quelle DE, Roussel MF, Sherr CJ, (1997) Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15: 203-211. doi:10.1038/sj.onc.1201178. PubMed: 9244355.
24. Calo E, Quintero-Estades JA, Danielian PS, Nedelcu S, Berman SD, et al. (2010) Rb regulates fate choice and lineage commitment in vivo. Nature 466: 1110-1114. doi:10.1038/nature09264. PubMed: 20686481.
25. Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, et al. (2001) The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 8: 303-316. doi:10.1016/S1097-2765(01)00327-6. PubMed: 11545733.
26. Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, et al. (2008) p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLOS ONE 3: e3707. doi:10.1371/journal.pone.0003707. PubMed: 19002260.
27. Yew TL, Chiu FY, Tsai CC, Chen HL, Lee WP, et al. (2011) Knockdown of p21(Cip1/Waf1) enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells. Aging Cell 10: 349-361. doi:10.1111/j.1474-9726.2011.00676.x. PubMed: 21342417.
28. Wang X, Kua HY, Hu Y, Guo K, Zeng Q, et al. (2006) p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol 172: 115-125. doi:10.1083/jcb.200507106. PubMed: 16380437.
29. Carbonneau CL, Despars G, Rojas-Sutterlin S, Fortin A, Le O, et al. (2012) Ionizing radiation-induced expression of INK4a/ARF in murine bone marrow-derived stromal cell populations interferes with bone marrow homeostasis. Blood 119: 717-726. doi:10.1182/blood-2011-06-361626. PubMed: 22101896.
30. Landry Y, Lê O, Mace KA, Restivo TE, Beauséjour CM, (2010) Secretion of SDF-1alpha by bone marrow-derived stromal cells enhances skin wound healing of C57BL/6 mice exposed to ionizing radiation. J Cell Mol Med 14: 1594-1604. PubMed: 19725920.
31. Kassem M, Marie PJ, (2011) Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. Aging Cell 10: 191-197. doi:10.1111/j.1474-9726.2011.00669.x. PubMed: 21210937.
32. Mehrara BJ, Avraham T, Soares M, Fernandez JG, Yan A, et al. (2010) p21cip/WAF is a key regulator of long-term radiation damage in mesenchyme-derived tissues. FASEB J 24: 4877-4888. doi:10.1096/fj.10-155762. PubMed: 20720160.
33. Abella A, Dubus P, Malumbres M, Rane SG, Kiyokawa H, et al. (2005) Cdk4 promotes adipogenesis through PPARgamma activation. Cell Metab 2: 239-249. doi:10.1016/j.cmet.2005.09.003. PubMed: 16213226.
34. Saeed H, Abdallah BM, Ditzel N, Catala-Lehnen P, Qiu W, et al. (2011) Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment. J Bone Miner Res Off J American Society For Bone Mineral Res 26: 1494-1505. doi:10.1002/jbmr.349. PubMed: 21308778.
35. Chen Q, Liu K, Robinson AR, Clauson CL, Blair HC, et al. (2012) DNA damage drives accelerated bone aging via an NF-kappaB-dependent mechanism. J Bone Miner Res Off J American Society For Bone Mineral Res.
36. Fumagalli M, Rossiello F, Clerici M, Barozzi S, Cittaro D, et al. (2012) Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol 14: 355-365. doi:10.1038/ncb2466. PubMed: 22426077.
37. Gregory CA, Gunn WG, Peister A, Prockop DJ, (2004) An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329: 77-84. doi:10.1016/j.ab.2004.02.002. PubMed: 15136169.
38. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. doi:10.1006/meth.2001.1262. PubMed: 11846609.